Castle Biosciences, Inc. (CSTL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.76
Day's range
$27.03

Castle Biosciences Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 08/07/2026 3.29 M $78.51 M   10.36% 10.83%
RTW INVESTMENTS, LP 08/14/2026 2.78 M $66.26 M   0.73% 9.14%
PRINCIPAL FINANCIAL GROUP INC 08/04/2026 1.73 M $41.18 M   -2.44% 5.68%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 1.23 M $29.25 M   4.16% 4.03%
ACADIAN ASSET MANAGEMENT LLC 08/13/2026 918.67 K $21.90 M   89.63% 3.02%
ALLIANZ ASSET MANAGEMENT GMBH 09/02/2026 879.26 K $20.97 M   8.37% 2.89%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 840.79 K $20.05 M   -2.44% 2.77%
STATE STREET CORP 09/22/2026 822.08 K $19.63 M   6.89% 2.75%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 08/14/2026 824.87 K $19.67 M   -12.31% 2.71%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 795.91 K $18.99 M   9.31% 2.62%
MACKENZIE FINANCIAL CORP 08/13/2026 793.51 K $18.93 M   970.70% 2.61%
DIMENSIONAL FUND ADVISORS LP 08/11/2026 791.09 K $18.87 M   -23.92% 2.60%
JEFFERIES FINANCIAL GROUP INC. 08/17/2026 647.39 K $15.44 M   100.00% 2.13%
QUBE RESEARCH & TECHNOLOGIES LTD 08/14/2026 589.30 K $14.05 M   5.31% 1.94%
AIGH CAPITAL MANAGEMENT LLC 08/07/2026 545.10 K $13.00 M   -7.70% 1.79%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 371.20 K $8.85 M   -30.33% 1.22%
GOLDMAN SACHS GROUP INC 08/14/2026 358.40 K $8.55 M   5.05% 1.18%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 357.32 K $8.52 M   100.00% 1.18%
KENNEDY CAPITAL MANAGEMENT LLC 08/14/2026 348.37 K $8.31 M   100.00% 1.15%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 331.73 K $7.91 M   -12.03% 1.09%
MORGAN STANLEY 08/13/2026 329.68 K $7.86 M   -23.14% 1.08%
PORTOLAN CAPITAL MANAGEMENT, LLC 08/14/2026 328.82 K $7.84 M   -75.65% 1.08%
PANAGORA ASSET MANAGEMENT INC 08/06/2026 301.04 K $7.18 M   35.39% 0.99%
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC 08/13/2026 292.47 K $6.98 M   82.04% 0.96%
NORTHERN TRUST CORP 08/13/2026 285.16 K $6.80 M   4.41% 0.94%
WASATCH ADVISORS LP 07/10/2026 279.35 K $6.66 M   -38.61% 0.92%
CITADEL ADVISORS LLC 09/02/2026 265.35 K $6.33 M   119.34% 0.87%
KORNITZER CAPITAL MANAGEMENT INC /KS 07/31/2026 264.24 K $6.30 M   -0.06% 0.87%
SILVERCREST ASSET MANAGEMENT GROUP LLC 08/14/2026 256.10 K $6.11 M   -4.63% 0.84%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 254.54 K $6.07 M   5.23% 0.84%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 254.54 K $6.07 M   100.00% 0.84%
ADVISORS CAPITAL MANAGEMENT, LLC 08/11/2026 238.20 K $5.68 M   -4.10% 0.78%
NEW YORK STATE COMMON RETIREMENT FUND 07/29/2026 234.75 K $5.60 M   0.73% 0.77%
PALISADE CAPITAL MANAGEMENT, LP 08/14/2026 231.93 K $5.53 M   -56.72% 0.76%
NUVEEN, LLC 08/11/2026 231.73 K $5.53 M   -55.62% 0.76%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 08/14/2026 221.34 K $5.28 M   -13.26% 0.73%
TREXQUANT INVESTMENT LP 08/14/2026 206.11 K $4.92 M   58.02% 0.68%
MILLENNIUM MANAGEMENT LLC 08/14/2026 205.37 K $4.90 M   -41.87% 0.68%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 197.49 K $4.71 M   4.93% 0.65%
AQR CAPITAL MANAGEMENT LLC 08/14/2026 166.57 K $3.97 M   156.73% 0.55%
FIRST TRUST ADVISORS LP 08/11/2026 145.06 K $3.46 M   100.00% 0.48%
PARKMAN HEALTHCARE PARTNERS LLC 08/14/2026 144.79 K $3.45 M   14.78% 0.48%
EMPOWERED FUNDS, LLC 08/17/2026 142.34 K $3.39 M   7.68% 0.47%
HRT FINANCIAL LP 08/14/2026 115.85 K $2.76 M   630.57% 0.38%
D. E. SHAW & CO., INC. 08/14/2026 112.79 K $2.69 M   -46.79% 0.37%
MAN GROUP PLC 08/14/2026 108.76 K $2.59 M   130.73% 0.36%
TWO SIGMA INVESTMENTS, LP 08/14/2026 100.37 K $2.39 M   -59.66% 0.33%
BANK OF AMERICA CORP /DE/ 08/14/2026 98.75 K $2.36 M   45.62% 0.32%
BANK OF NEW YORK MELLON CORP 08/06/2026 98.02 K $2.34 M   10.56% 0.32%
FRANKLIN RESOURCES INC 08/13/2026 97.73 K $2.33 M   7.51% 0.32%

Castle Biosciences Inc institutional Ownership - FAQ's

During the previous two years, 255 institutional investors and hedge funds held shares of Castle Biosciences Inc. The most heavily invested institutionals were:

Versant Capital Management, Inc: 154

BlackRock, Inc.: 3.29 M

RTW INVESTMENTS, LP: 2.78 M

PRINCIPAL FINANCIAL GROUP INC: 1.73 M

VANGUARD CAPITAL MANAGEMENT LLC: 1.23 M

ACADIAN ASSET MANAGEMENT LLC: 918,668

92.62% of Castle Biosciences Inc stock is owned by institutional investors.

Institutional investors have bought a total of 34.46 M shares in the last 24 months. This purchase volume represents approximately $931.12 M in transactions.